416 related articles for article (PubMed ID: 19555717)
1. Cooperative properties of cytochromes P450.
Denisov IG; Frank DJ; Sligar SG
Pharmacol Ther; 2009 Nov; 124(2):151-67. PubMed ID: 19555717
[TBL] [Abstract][Full Text] [Related]
2. A novel type of allosteric regulation: functional cooperativity in monomeric proteins.
Denisov IG; Sligar SG
Arch Biochem Biophys; 2012 Mar; 519(2):91-102. PubMed ID: 22245335
[TBL] [Abstract][Full Text] [Related]
3. Elucidation of distinct ligand binding sites for cytochrome P450 3A4.
Hosea NA; Miller GP; Guengerich FP
Biochemistry; 2000 May; 39(20):5929-39. PubMed ID: 10821664
[TBL] [Abstract][Full Text] [Related]
4. New findings in studies of cytochromes P450.
Myasoedova KN
Biochemistry (Mosc); 2008 Sep; 73(9):965-9. PubMed ID: 18976212
[TBL] [Abstract][Full Text] [Related]
5. The one-electron autoxidation of human cytochrome P450 3A4.
Denisov IG; Grinkova YV; McLean MA; Sligar SG
J Biol Chem; 2007 Sep; 282(37):26865-26873. PubMed ID: 17650504
[TBL] [Abstract][Full Text] [Related]
6. Kinetics and thermodynamics of ligand binding by cytochrome P450 3A4.
Isin EM; Guengerich FP
J Biol Chem; 2006 Apr; 281(14):9127-36. PubMed ID: 16467307
[TBL] [Abstract][Full Text] [Related]
7. Atypical Michaelis-Menten kinetics in cytochrome P450 enzymes: A focus on substrate inhibition.
Leow JWH; Chan ECY
Biochem Pharmacol; 2019 Nov; 169():113615. PubMed ID: 31445022
[TBL] [Abstract][Full Text] [Related]
8. Is there a toxicological advantage for non-hyperbolic kinetics in cytochrome P450 catalysis? Functional allostery from "distributive catalysis".
Atkins WM; Lu WD; Cook DL
J Biol Chem; 2002 Sep; 277(36):33258-66. PubMed ID: 12082118
[TBL] [Abstract][Full Text] [Related]
9. Enzyme Kinetics of Oxidative Metabolism-Cytochromes P450.
Korzekwa K
Methods Mol Biol; 2021; 2342():237-256. PubMed ID: 34272697
[TBL] [Abstract][Full Text] [Related]
10. Multiple sequential steps involved in the binding of inhibitors to cytochrome P450 3A4.
Isin EM; Guengerich FP
J Biol Chem; 2007 Mar; 282(9):6863-74. PubMed ID: 17200113
[TBL] [Abstract][Full Text] [Related]
11. Cytochromes P450 as versatile biocatalysts.
Bernhardt R
J Biotechnol; 2006 Jun; 124(1):128-45. PubMed ID: 16516322
[TBL] [Abstract][Full Text] [Related]
12. Pyrene.pyrene complexes at the active site of cytochrome P450 3A4: evidence for a multiple substrate binding site.
Dabrowski MJ; Schrag ML; Wienkers LC; Atkins WM
J Am Chem Soc; 2002 Oct; 124(40):11866-7. PubMed ID: 12358527
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of atypical cytochrome P450 kinetics with two-substrate models: evidence that multiple substrates can simultaneously bind to cytochrome P450 active sites.
Korzekwa KR; Krishnamachary N; Shou M; Ogai A; Parise RA; Rettie AE; Gonzalez FJ; Tracy TS
Biochemistry; 1998 Mar; 37(12):4137-47. PubMed ID: 9521735
[TBL] [Abstract][Full Text] [Related]
14. Heterotropic cooperativity of cytochrome P450 3A4 and potential drug-drug interactions.
Tang W; Stearns RA
Curr Drug Metab; 2001 Jun; 2(2):185-98. PubMed ID: 11469725
[TBL] [Abstract][Full Text] [Related]
15. Non-Michaelis-Menten kinetics in cytochrome P450-catalyzed reactions.
Atkins WM
Annu Rev Pharmacol Toxicol; 2005; 45():291-310. PubMed ID: 15832445
[TBL] [Abstract][Full Text] [Related]
16. Human cytochrome P450 enzymes bind drugs and other substrates mainly through conformational-selection modes.
Guengerich FP; Wilkey CJ; Phan TTN
J Biol Chem; 2019 Jul; 294(28):10928-10941. PubMed ID: 31147443
[TBL] [Abstract][Full Text] [Related]
17. Heterotropic and homotropic cooperativity by a drug-metabolising mutant of cytochrome P450 BM3.
van Vugt-Lussenburg BM; Damsten MC; Maasdijk DM; Vermeulen NP; Commandeur JN
Biochem Biophys Res Commun; 2006 Aug; 346(3):810-8. PubMed ID: 16777067
[TBL] [Abstract][Full Text] [Related]
18. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
[TBL] [Abstract][Full Text] [Related]
19. Allosteric P450 mechanisms: multiple binding sites, multiple conformers or both?
Davydov DR; Halpert JR
Expert Opin Drug Metab Toxicol; 2008 Dec; 4(12):1523-35. PubMed ID: 19040328
[TBL] [Abstract][Full Text] [Related]
20. Prediction of amino acid residues participated in substrate recognition by cytochrome P450 subfamilies with broad substrate specificity.
Zharkova MS; Sobolev BN; Yu Oparina N; Veselovsky AV; Archakov AI
J Mol Recognit; 2013 Feb; 26(2):86-91. PubMed ID: 23334916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
